Laura Strohmeyer

LAURA STROHMEYER

Employment

Clinical Director, GI

AmSurg Corp, Dallas, TX

Education

RN Diploma

Board Certifications: CGRN

Certified Administrator Surgery Center (CASC)

ABCGN/SGNA Involvement

National:

SGNA Board of Directors, 2006-2010

SGNA Member, 26 years

National SIG member, 13 years

SGNA mentor for board certification, 2 years

SGNA Lab Management Special Interest Group-Chair, May 00-01

SGNA Newsletter Editor, May 1999- May 2001

SGNA Web Site Committee May 1998-2001

ABCGN (formerly Certifying Board of Gastroenterology Nurses and Associates CBGNA)

Board of Directors, 11/98-5/02

National House of Delegates 1995, 1997

Regional:

Board of Directors, SGNA Northern Texas Region, 2003-present

NTSGNA Regional Director 2008-present

NTSGNA Regional President 2003

LSGNA Regional President 1996, 1998

Other Involvement

Association for Professionals in Infection Control and Epidemiology, Inc., member: 2009-present

American Association of Legal Nurse Consultants, member: 2007-2009

Texas Organization of Nurse Executives, member: 2003-2005

Louisiana Organization of Nurse Executives, member: 1998-2000

Crohn’s Colitis Foundation of America, Inc., 1998-2010

North Texas CCFA Board of Trustees 2002-2005

Founder and Co-Facilitator - Dallas CCFA Education and Self Help Support Group 04-09

Founder and Co-Facilitator - Plano CCFA Education and Self Help Support Group 02-04

Publications

1. Irritable Bowel Syndrome: Not Just a Gut Feeling, 2009, Nursing Spectrum
2. Finding Support when you have Inflammatory Bowel Syndrome, May 09: Vol 14; Salix-Online Patient Newsletter
3. The Scoop in the Scope- Prep Tips form a Pro, March 10: Vol 19; Salix-Online Patient Newsletter

Presentations

Research

1. Clinical Study Coordinator: GHBA/Janssen-JR051:619/1203 : Clinical Evaluation of Cisapride in the Treatment of Chronic Gastroesophageal Reflux disease-A Multicenter Dose-Response Trial-1989-1990
2. Clinical Study Coordinator: GHBA-170 : A 42 Day, Double-Blind Parallel Groupmulti center Study to Compare the Safety and Efficacy of Three Dose Levels of Budenoside with Placebo in Adults Patients with Distal Ulcerative Colitis/Proctitis-1991.
3. Clinical Study Coordinator: GHBA/Glaxo-H2B-302 : A Multi center, Randomized, Double-blind, Placebo-Controlled, Evaluation of Healing and Relapse Rates Following Oral GR122311X Compared with GR88502X, Ranitidine and Placebo in Patients with Duodenal Ulcer-1992-94.

1. 4. Clinical Study Coordinator: -GHBA/Glaxo-H2B-312 : A Multicenter, Randomized, Double-blind, Placebo-Controlled, Evaluation of Healing and Rates Following Oral GR122311X Compared with GR88502X,Ranitidine and Placebo in Patients with Benign Gastric Ulcer-1992-95.

1. Clinical Study Coordinator -CTMS/Glaxo- H2B-306: A Multi center, Randomized, Double-Blind, Placebo-Controlled, Evaluation of Healing and Relapse Rates Following Oral GR122311X in Combination with Clarithromycin, Compared with GR122311X, Clarithromycin, and Placebo in Patients with Duodenal Ulcer-1993-94.
2. Clinical Study Coordinator -GHBA/Astra Hässle-I-1002a.b. and QL-Healing and Prevention of Gastroduodenal Lesions Induced by Non-Steroidal, Anti- inflammatory Drugs During Oral Treatment with Omeprazole or Misoprostal in Patients with Arthritic Disease-1993-1994.
3. Clinical Study Coordinator- Janssen- CIS-USA-52A-Clinical Evaluation of Propulsid (cisapride)Tablets, 20 mg B.I.D., in the Treatment of Subjects with Symptoms of Chronic Esophageal Reflux Disease 1994-1995.
4. Clinical Study Coordinator- Glaxo-H2BA3001 -A Randomized, Double-Blind, Multi-Center, Evaluation of H.Pylori Eradication Rates following Oral GR122311X PlusClarithromycin 500 mg T.I.D. Compared to Oral GR122311X Plus Clarithromycin500mg BID in Subjects with Duodenal Ulcer. 1995-1996.

Awards

CBGNA- 2007 Certified Professional of the Year, 5/22/07

Texas Nurses Association: Great 100 Nurses, 5/9/2007

Proctor & Gamble- PHD GI Professional of the Year- 3/06

2000 Edith LoBue Leadership Award, Baton Rouge General Med Ctr., 5/11/00

Essay

I have worked in GI Endoscopy for over 28 years and have been a certified GI RN for 21 years. The field of GI Nursing has offered me numerous opportunities to help patients, educate the public, motivate my peers, participate in professional organizations and achieve my professional goals.

I have participated in numerous health fairs and programs to promote colon cancer awareness and treatment of GI diseases. My most rewarding experience working with the public was facilitating an IBD Support Group for seven years. When I participate in direct patient care, I think it is important to think of each patient as an individual and work with physicians to meet all patient need during each procedure.

I believe that certification in your specialty is not only a means of personal satisfaction, but a way to encourage certification to your peers. I have given numerous presentations on the importance of certification and organized study groups for those preparing for certification. It has been rewarding making a difference in this profession through leadership positions with SGNA (regional and national) and ABCGN.

In the last two years I have started working in the ambulatory setting, and I work closely with 16 ambulatory endoscopy centers. I enjoy the opportunity to share my passion for GI nursing, and encouraging others to get all they can from GI nursing.